Isabelle Ingrand

1.5k total citations
60 papers, 1.1k citations indexed

About

Isabelle Ingrand is a scholar working on Oncology, Epidemiology and General Health Professions. According to data from OpenAlex, Isabelle Ingrand has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Epidemiology and 7 papers in General Health Professions. Recurrent topics in Isabelle Ingrand's work include Colorectal Cancer Screening and Detection (6 papers), Genetic factors in colorectal cancer (5 papers) and Fungal Plant Pathogen Control (5 papers). Isabelle Ingrand is often cited by papers focused on Colorectal Cancer Screening and Detection (6 papers), Genetic factors in colorectal cancer (5 papers) and Fungal Plant Pathogen Control (5 papers). Isabelle Ingrand collaborates with scholars based in France, United States and Italy. Isabelle Ingrand's co-authors include Pierre Ingrand, J. Girault, J. B. Fourtillan, J Decourt, A.M. Brisson, Virginie Migeot, Michel Beauchant, Gautier Défossez, Claire Lafay‐Chebassier and Marc Paccalin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Isabelle Ingrand

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Ingrand France 21 180 135 125 125 109 60 1.1k
Abdollah Omidi Iran 25 120 0.7× 133 1.0× 43 0.3× 114 0.9× 254 2.3× 162 1.7k
Naoki Nakaya Japan 25 215 1.2× 305 2.3× 167 1.3× 188 1.5× 208 1.9× 92 2.5k
Dimitrios Kouvelas Greece 22 55 0.3× 196 1.5× 51 0.4× 127 1.0× 161 1.5× 92 1.4k
Linda L. D. Zhong Hong Kong 26 296 1.6× 174 1.3× 82 0.7× 120 1.0× 455 4.2× 127 1.9k
Marcello Casaccia Bertoluci Brazil 21 74 0.4× 238 1.8× 130 1.0× 166 1.3× 261 2.4× 51 1.5k
J. B. Ruidavets France 17 65 0.4× 245 1.8× 66 0.5× 176 1.4× 202 1.9× 28 1.4k
Lekha Saha India 17 106 0.6× 186 1.4× 48 0.4× 58 0.5× 273 2.5× 64 1.4k
Bruno Imthurn Switzerland 34 116 0.6× 317 2.3× 38 0.3× 78 0.6× 350 3.2× 106 3.2k
Jinhee Park United States 26 148 0.8× 122 0.9× 74 0.6× 451 3.6× 263 2.4× 97 1.9k
Fariba Mirzaei Iran 18 146 0.8× 318 2.4× 41 0.3× 188 1.5× 142 1.3× 49 1.6k

Countries citing papers authored by Isabelle Ingrand

Since Specialization
Citations

This map shows the geographic impact of Isabelle Ingrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Ingrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Ingrand more than expected).

Fields of papers citing papers by Isabelle Ingrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Ingrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Ingrand. The network helps show where Isabelle Ingrand may publish in the future.

Co-authorship network of co-authors of Isabelle Ingrand

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Ingrand. A scholar is included among the top collaborators of Isabelle Ingrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Ingrand. Isabelle Ingrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Randrian, Violaine, Camille Evrard, Claire Boyer, et al.. (2025). COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study. BMC Cancer. 25(1). 398–398.
2.
Ingrand, Isabelle, Gautier Défossez, Claire Lafay‐Chebassier, et al.. (2019). Serious adverse effects occurring after chemotherapy: A general cancer registry‐based incidence survey. British Journal of Clinical Pharmacology. 86(4). 711–722. 21 indexed citations
3.
Guellec, Chantal Barin‐Le, Claire Lafay‐Chebassier, Isabelle Ingrand, et al.. (2019). Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France. European Journal of Cancer. 124. 37–46. 42 indexed citations
4.
Roubaud‐Baudron, Claire, E. Forestier, T. Fraisse, et al.. (2016). Tolerance of subcutaneously administered antibiotics: a French national prospective study. Age and Ageing. 46(1). 151–155. 29 indexed citations
5.
Laroche, Marie‐Laure, Marie‐Christine Pérault‐Pochat, Isabelle Ingrand, et al.. (2013). Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross‐sectional study. Pharmacoepidemiology and Drug Safety. 22(9). 952–960. 39 indexed citations
6.
Marcelli, Daniel, et al.. (2011). Scale for the Evaluation of Circumstances Surrounding an Accident and the Risk of Recurrence (ECARR): A Prospective Validation Study of Accident Repetition. 54(1). 253–299. 3 indexed citations
7.
Ingrand, Isabelle, Pierre Ingrand, Brigitte Gilbert‐Dussardier, et al.. (2011). Altered quality of life in Rendu-Osler-Weber disease related to recurrent epistaxis. Rhinology Journal. 49(2). 155–162. 38 indexed citations
8.
Maurel, D, et al.. (2011). Combined effects of chronic alcohol consumption and physical activity on bone health: study in a rat model. European Journal of Applied Physiology. 111(12). 2931–2940. 17 indexed citations
9.
10.
Ingrand, Isabelle, et al.. (2010). Determinants of participation in colonoscopic screening by siblings of colorectal cancer patients in France. BMC Cancer. 10(1). 355–355. 24 indexed citations
11.
Bouche, Gauthier, et al.. (2010). Determinants of variability in waiting times for radiotherapy in the treatment of breast cancer. Radiotherapy and Oncology. 97(3). 541–547. 11 indexed citations
12.
Chavant, François, Julie Deguil, Stéphanie Pain, et al.. (2009). Imipramine, in Part through Tumor Necrosis Factor α Inhibition, Prevents Cognitive Decline and β-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease. Journal of Pharmacology and Experimental Therapeutics. 332(2). 505–514. 64 indexed citations
13.
14.
Oberti, Frédéric, Pierre Bernard, Éric Bartoli, et al.. (2007). Management practices for gastrointestinal hemorrhage related to portal hypertention in cirrhotic patients: evaluation of the impact of the Paris consensus workshop. Gastroentérologie Clinique et Biologique. 31(11). 970–974. 6 indexed citations
15.
Défossez, Gautier, Simone Mathoulin‐Pélissier, Isabelle Ingrand, et al.. (2007). Satisfaction with care among patients with non-metastatic breast cancer: development and first steps of validation of the REPERES-60 questionnaire. BMC Cancer. 7(1). 129–129. 42 indexed citations
16.
Ingrand, Isabelle, et al.. (2006). Comportements de santé des étudiants d'IUT de l'Université de Poitiers. Santé Publique. Vol. 18(2). 195–205. 8 indexed citations
17.
Salazar, Daniel E., et al.. (1999). Pharmacokinetic evaluation of co-administration of nefazodone and lithium in healthy subjects. European Journal of Clinical Pharmacology. 54(12). 923–928. 8 indexed citations
18.
Fourtillan, J. B., A.M. Brisson, J. Girault, et al.. (1995). [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].. PubMed. 50(2). 137–44. 64 indexed citations
19.
Couet, William, et al.. (1989). [Pharmacokinetics of ponsinomycin administered in a syrup form in single 400-800 and 1200 mg doses in healthy volunteers].. PubMed. 37(5). 428–32. 4 indexed citations
20.
Couet, William, et al.. (1989). Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophylline. European Journal of Clinical Pharmacology. 37(1). 101–104. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdollah Omidi Breakdown of academic impact, for papers by Naoki Nakaya Breakdown of academic impact, for papers by Dimitrios Kouvelas Breakdown of academic impact, for papers by Linda L. D. Zhong Breakdown of academic impact, for papers by Marcello Casaccia Bertoluci Breakdown of academic impact, for papers by J. B. Ruidavets Breakdown of academic impact, for papers by Lekha Saha Breakdown of academic impact, for papers by Bruno Imthurn Breakdown of academic impact, for papers by Jinhee Park Breakdown of academic impact, for papers by Fariba Mirzaei
Rankless by CCL
2026